fluorodeoxyglucose f18 has been researched along with Cavernous Angioma, Central Nervous System in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Healy, GM; Killeen, RP; Kinsella, J; Redmond, CE | 1 |
Kawabe, T; Mineura, K; Miyamoto, J; Owada, K; Sasajima, H; Tatsuzawa, K | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Cavernous Angioma, Central Nervous System
Article | Year |
---|---|
Usefulness and limitations of fluorine-18-fluorodeoxyglucose positron emission tomography for the detection of malignancy of orbital tumors.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Astrocytoma; Carcinoma, Adenoid Cystic; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioblastoma; Hemangioma, Cavernous, Central Nervous System; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Melanoma; Middle Aged; Neurilemmoma; Optic Nerve Neoplasms; Orbital Neoplasms; Orbital Pseudotumor; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2008 |
1 other study(ies) available for fluorodeoxyglucose f18 and Cavernous Angioma, Central Nervous System
Article | Year |
---|---|
PET imaging of subclinical seizure associated with intracranial cavernous malformations.
Topics: Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Hemangioma, Cavernous, Central Nervous System; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |